Dr. Jordan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Suite 7200
3800 Chapman Blvd
Orange, CA 92868Phone+1 714-456-6717
Education & Training
- University of Minnesota Medical SchoolPost-Doctoral Fellowship, 1984 - 1986
- Cleveland Clinic FoundationFellowship, Renal Transplantation and Renovascular Surgery, 1983 - 1984
- University of Toronto Gallie ProgramFRCS (C), Urology Residency, 1978 - 1983
- Hospital for Sick ChildrenInternship, 1977 - 1978
- University of Toronto Faculty of MedicineClass of 1977, MD, Junior AOA, Gold Medal in Surgery, Irving Heward Cameron Scholarship in Surgery
- University of TorontoPre-Med, Arts and Science, 1971 - 1973
Certifications & Licensure
- CA State Medical License 2013 - 2025
- NJ State Medical License 2003 - 2025
- PA State Medical License 1989 - 2006
- MN State Medical License 1984 - 1995
- American Board of Urology Urology
Awards, Honors, & Recognition
- Best Doctors in Orange County 2018
- Best Doctors in Orange County 2018
- Top Urologists US News and World Report 2013
- Join now to see all
Clinical Trials
- Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer Start of enrollment: 2011 Aug 18
Publications & Presentations
PubMed
- 6 citationsThe Impact of Visiting Rotations on the Urology Residency Match: Insights and Perspectives From the 2021-2022 Applicants.Miyad Movassaghi, Anton Gillespie, Christopher M Deibert, Mark Jordan, Gary E Lemack
Urology. 2022-12-01 - 58 citationsEvaluation of Urology Residency Training and Perceived Resident Abilities in the United States.Zhamshid Okhunov, Shoaib Safiullah, Roshan M. Patel, Samuel Juncal, Harwood Garland
Journal of Surgical Education. 2019-07-01 - 15 citationsSystemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease.Neil R. Parikh, Claudia Huiza, Jill S. Patel, Sonny Tsai, Nathisha Kalpage
BMC Cancer. 2019-04-01
Journal Articles
- When Anti-Aging Studies Meet Cancer Chemoprevention: Can Anti-Aging Agent Kill Two Birds with One Blow?Yokoyama NN, Denmon A, Uchio E, Jordan M, Mercola D, and Zi X, Curr Pharmacol Rep, 1/1/2015
- Urologic Workup of the Transplant RecipientChamberlin J and Jordan M, AUA Update, 1/1/2014
- Significance of divergent expression of prostaglandin EP4 and EP3 receptors in human prostate cancerHuang HF, Murphy TF, Shu P, Aisner S, Jordan ML., Molecular Cancer Res, 1/1/2013
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Prostaglandin EP4 receptor knockdown suppresses prostate cancer growth in vivoHuang HF, Murphy TF, Shu P, Lewandoski P, Pregenzer G, Carpenter CP, Jordan ML, American Urological Association Annual Meeting, Washington DC, 1/1/2011
- Differential expression of prostaglandin receptors in prostate cancer: A novel therapeutic target?Huang HF, Murphy TF, Shu P, Aisner S, Jordan ML, American Urological Association Annual Meeting, Washington DC, 1/1/2011
- Prostaglandin receptors differentially regulate prostate cancer growth: A novel treatment target?Huang HF, Murphy TF, Shu P, Aisner S, Jordan ML, American Association of Cancer Research Annual Meeting, 1/1/2010
- Join now to see all
Lectures
- Take Home Message-Renovascular Surgery and TransplantationAnaheim, CA - 1/7./2001
- ACGME Site Visit � What do I need to know?1/19/2007
- Update on Prostate Cancer 2007UMDNJ-NJMS - 1/2./2007
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: